Multivessel coronary disease diagnosed at the time of primary PCI for STEMI: Complete revascularisation versus conservative strategy. Prague-13 trial;Mnohočetné postižení věnčitých tepen dia gnostikované při pPCI pro STEMI: Kompletní revaskularizace nebo konzervativní léčba. Studie Prague- 13

Kardiologicka Revue

Volumn 17, Issue 3, 2015, Pages 214-220

  Hlinomaz, Ota ^a   Groch, L ^a   Polokova K ^a   Lehar, F ^a   Vekov, T ^b   Petkov, R ^b   Stojnev, M ^b   Griva M ^c   Sitar, J ^a   Rezek, M ^a   Novak M ^a   Semenka J ^a   Penkov, N ^b  

^a Interní kardioangiologická klinika ^*  (Czech Republic)

^b Bulharský kardiologický institut   (Czech Republic)

^c Kardiovaskulární centrum Interní klinika IPVZ Krajská nemocnice T Bati a s   (Czech Republic)

Author keywords

Acute myocardial infarction; Multivessel coronary disease; Primary PCI; Revascularisation

Indexed keywords

ACUTE HEART INFARCTION; ANGINA PECTORIS; ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION;

EID: 84944198533     PISSN: 12124540     EISSN: 18018653     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003; 361: 13-20.
2. O’Gara PT, Kushna FG, Ascheim DD et al. 2013 ACCF/AHA Guideline for the management of 1st- elevation myocardial infarction: executive sum mary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013; 127: 529-555. doi: 10.1161/CIR.0b013e3182742c84.
3. Steg G, James SK, Atar D et al. The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33: 2569-2619. doi: 10.1093/eurheartj/ehs215.
4. Windecker S, Kolh P, Alfonso F et al. 2014 ESC/EACTS Guidelines on myocardial revascularization. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio- Thoracic Surgery (EACTS). Eur Heart J 2014; 35: 3541-3619. doi: 10.1093/eurheartj/ehu278.
5. Patel MR, Dehmer GJ, Hirshfeld JW et al. ACCF//SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: A Report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology: Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography. Circulation 2009; 119: 1330-1352. doi: 10.1161/CIRCULATIONAHA.108.191768.
6. Bangalore S, Faxon DP. Coronary intervention in patients with acute coronary syndrome: does every culprit lesion require revascularization? Curr Cardiol Rep 2010; 12: 330-337. doi: 10.1007/s11886-010-0115-8.
7. Di Mario C, Mara S, Flavio A et al. Single vs. multivessel treatment during primary angioplasty: results of the multicentre randomised HEpacoat for cuLPrit or multivessel stenting for Acute Myocardial Infarction (HELP AMI) Study. Int J Cardiovasc Intervent 2004; 6: 128-133.
8. Qarawani D, Nahir M, Abboud M et al. Culprit only versus complete revascularization during primary PCI. Int J Cardiol 2008; 123: 288-292
9. Corpus RA, House JA, Marso SP et al. Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction. Am Heart J 2004; 148: 493-500.
10. Khattab AA, Abdel- Wahab M, Röther C et al. Multi-vessel stenting during primary percutaneous coronary intervention for acute myocardial infarction: a singlecenter experience. Clin Res Cardiol 2008; 97: 32-38.
11. Rigattieri S, Biondi- Zoccai G, Silvestri P et al. Management of multivessel coronary disease after ST elevation myocardial infarction treated by primary angioplasty. J Interv Cardiol 2008; 21: 1-7.
12. Kornowski R, Mehran R, Dangas G et al. Prognostic impact of staged vs. "one- time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS- AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. J Am Coll Cardiol 2011; 58: 704-711.
13. Ochala A, Smolka GA, Wojakowski W et al. The function of the left ventricle after complete multivessel one-stage percutaneous coronary intervention in patients with acute myocardial infarction. J Invasive Cardiol 2004; 16: 699-702.
14. Vlaar PJ, Mahmoud KD, Holmes DR Jr. et al. Culprit vessel only vs. multivessel and staged percutaneous coronary intervention for multivessel disease in pa tients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis. J Am Coll Cardiol 2011; 58: 692-703. doi: 10.1016/j.jacc.2011.03.046.
15. Abe D, Sato A, Hoshi T et al. Initial culprit- only versus initial multivessel percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: results from the Ibaraki Cardiovascular Assessment Study registry. Heart Vessels 2014; 29: 171-177. doi: 10.1007/s00380-013-0342-1.
16. Varani E, Balducelli M, Aquilina M et al. Single or multivessel percutaneous coronary intervention in ST-elevation myocardial infarction patients. Catheter Cardiovasc Interv 2008; 72: 927-933. doi: 10.1002/ccd.21722.
17. Hannan EL, Samadashvili Z, Walford G et al. Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease. JACC Cardiovasc Interv 2010; 3: 22-31. doi: 10.1016/j.jcin.2009.10.017.
18. Dambrink JH, Debrauwere JP, Hof AW et al. Non- culprit lesions detected during primary PCI: treat invasively or follow the guidelines? EuroIntervention 2010; 5: 968-975.
19. Politi L, Sgura F, Rossi R et al. A randomised trial of target- vessel vs. multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during longterm follow-up. Heart 2010; 96: 662-667. doi: 10.1136/hrt.2009.177162.
20. Manari A, Varani E, Guastaroba P et al. Long-term outcome in patients with ST segment elevation myocardial infarction and multivessel disease treated with culprit- only, immediate, or staged multivessel percutaneous revascularization strategies: Insights from the REAL registry. Catheter Cardiovasc Interv. 2014; 84: 912-922. doi: 10.1002/ccd.25374.
21. Wald DS, Morris JK, Wald NJ et al. Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med 2013; 369: 1115-1123. doi: 10.1056/NEJMoa1305520.
22. Gershlick AH, Khan JN, Kelly DJ et al. Randomized trial of complete versus lesion- only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial. J Am Coll Cardiol 2015; 65: 963-972. doi: 10.1016/j.jacc.2014.12.038.
23. Engstroem T. The third Danish study of optimal acute treatment of patients with ST-segment elevation myocardial infarction primary PCI in multivessel disease DANAMI3-PRIMULTI. San Diego: ACC 2015.
24. El- Hayek GE, Gershlick AH, Hong MK et al. Meta-Analysis of Randomized Controlled Trials Comparing Multivessel Versus Culprit- Only Revascularization for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease Undergoing Primary Percutaneous Coronary Intervention. Am J Cardiol 2015; 115: 1481-1486. doi: 10.1016/j.amjcard.2015.02.046.
25. Bainey KR, Mehta SR, Lai T et al. Complete vs culprit- only revascularization for patients with multivessel disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: A systemic review and meta-analysis. Am Heart J 2014; 167: 1-14. doi: 10.1016/j.ahj.2013.09.018.
26. Sarathy K, Nagaraja V, Kapur A et al. Target- vessel versus multivessel revascularisation in st- elevation myocardial infarction: a meta-analysis of randomised trials. Heart Lung Circ 2014; 24: 327-334. doi: 10.1016/j.hlc.2014.10.013.
27. Moretti C, D'Ascenzo F, Quadri G et al. Management of multivessel coronary disease in STEMI patients: a systematic review and meta-analysis. Int J Cardiol 2015; 179: 552-557. doi: 10.1016/j.ijcard.2014.10.035.
28. Yeh RW, Drachman DE. Culprit only, multivessel, or staged multivessel intervention in STEMI: new insights or insurmountable methodologic obstacles? Catheter Cardiovasc Interv 2014; 84: 923-924. doi: 10.1002/ccd.25673.
29. Widimsky P, Holmes DR. How to treat patients with ST-elevation acute myocardial infarction and multi-vessel disease? Eur Heart J 2011; 32: 396-403. doi: 10.1093/eurheartj/ehq410.
30. Bailey SR. Revascularization for ST segment elevation MI: advances in treatment of multivessel disease in STEMI. Catheter Cardiovasc Interv 2014; 84: 857-858.
31. Pollack A, Mohanty BD, Handa R et al. Preventive Stenting in Acute Myocardial Infarction. JACC Cardiovasc Interv 2015; 8: 131-138. doi: 10.1016/j.jcin.2014.09.006.
32. Goldstein JA, Demetriou D, Grines CL et al. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 2000; 343: 915-922.
33. Takano M, Inami S, Ishibashi F et al. Angioscopic follow-up study of coronary ruptured plaques in nonculprit lesions. J Am Coll Cardiol 2005; 45: 652-658.
34. Ambrose JA, D'Agate DJ. Plaque rupture and intracoronary thrombus in nonculprit vessels: an eyewitness account. J Am Coll Cardiol 2005; 45: 659-660.
35. Glaser R, Selzer F, Faxon DP et al. Clinical progression of incidental, asymp tomatic lesions discovered during culprit vessel coronary intervention. Circulation 2005; 111: 143-149.